Research & Development

亚洲色图亚洲综合婷婷六月丁视频二区亚洲欧美俄罗斯找到2018年失踪的母老虎 身体状况良好


  雲瑯對于三面包圍鉤子山的匈奴人其實不是很在意,他早就演練過無數遍,只要大群的匈奴人越過木樁林,跨過壕溝,騎都尉的撤退行動就會立刻施行。   雲瑯嘿嘿笑道︰“她要把匈奴人的尸體慢慢的分解,切碎,扒皮,然後一點點的研究,想看看匈奴人跟我們大漢人在身體構造上有什麼不同。然後有針對性的考慮怎麼治病!”亚洲色图   伊秩斜朝天怒吼道︰“是誰在害我!”亚洲综合婷婷六月丁   雲瑯的身體搖晃了兩下,扶著山洞洞壁這才站穩,顫聲道︰“拖出去!”视频二区亚洲欧美   見雲瑯奇怪的看著他,裴炎可能是心情好又解釋道︰“褐發藍楮,張騫告訴過我。”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo